New Delhi metallo - Beta lactamase - 1 containing enterobacteriaceae: Origin, Diagnosis, treatment and public health concern

Pan African Medical Journal

Volumn 11, Issue , 2012, Pages 22-

  Charan, Jaykaran ^a   Mulla, Summaiya ^a   Ryavanki, Sridhar ^a   Kantharia, Naresh ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Antibiotics resistance; Carbapenemases; Enterobacteriaceae; New Delhi Beta metallo lactamase

Indexed keywords

CARBAPENEM DERIVATIVE; COLISTIN; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; TIGECYCLINE; UNCLASSIFIED DRUG; BETA LACTAMASE; BETA LACTAMASE NDM 1; BETA-LACTAMASE NDM-1;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; DISK DIFFUSION; ENTEROBACTERIACEAE; ENZYME ASSAY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE IDENTIFICATION; IN VITRO STUDY; KLEBSIELLA; NEW DELHI METALLO BETA LACTAMASE 1 GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PUBLIC HEALTH PROBLEM; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GENETICS; HUMAN; INFECTION CONTROL; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY; PREVALENCE; PUBLIC HEALTH; REVIEW;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PUBLIC HEALTH;

EID: 84865304378     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Abdul Ghafur K. An obituary-On the death of antibiotics. Journal of the association of physicians of India. 2010; 58: 143-44. This article on PubMed
2. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010 Sep; 10(9): 597-602. This article on PubMed
3. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011; 11: 355-62. This article on PubMed
4. Kant S, Haldar P. Is NDM-1 actually being imported to UK from India. Indian J Public Health. 2010; 54: 151-54. This article on PubMed
5. Mahajan A, Tandon VR. New Delhi metallo (Beta-Lactamase 1): Fact or Fiction. JK Science. 2010; 12: 109
6. Nataraj G. New Delhi metallo beta-lactamase: What is in a name?J Postgrad Med. 2010 Oct-Dec; 56(4): 251-2. This article on PubMed
7. Singh A R. Science, Names Giving and Names Calling: Change NDM-1 to PCM. Mens Sana Monogr. 2011 Jan; 9(1): 294-319. This article on PubMed
8. Kaul TK. Medical Tourism and New Delhi Metallo b lactamase 1 A Concern and Threat. J Anaesthesiol Clin Pharmacol. 2010 Oct; 26(4): 437-8. This article on PubMed
9. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009 Dec; 53(12): 5046-54. This article on PubMed
10. Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R. New Delhi metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India. 2010 Mar; 58: 147-9. This article on PubMed
11. Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumanii from India. J Antimicrob Chemother. 2010; 65: 2253-2270. This article on PubMed
12. Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P. Emergence of Metallo-b-lactamase-NDM-1-Producing multidrug resistant Escherichia coli in Australia. Antimicrobial Agents and Chemotherapy. 2010; 54: 4914-4916. This article on PubMed
13. Wu HS, Chen TL, Chen ICJ, Huang MS, Wang FD, Fung CP, et al. First Identification of a patient colonized with Klebsiella pneumonia carrying blaNDM-1 in Taiwan. J Chin Med Assoc. 2010; 73: 596-598. This article on PubMed
14. Struelens MI, Monnet DL, Magiokaros AP, Santos O Conner F, Giesecke J, the Europian NDM-1 survey participants. New Delhi matallo-beta-lactamase 1-producing enterobacteriaceae: emergence and response in Europe. Euro Surveill. 2010 Nov 18; 15(46). pii: 19716. This article on PubMed
15. Chihara S, Okuzumi K, Yamamoto Y, Oikawa S, Hishinuma A. First case of New Delhi metallo-b-lactamase 1 producing Escherichia coli infection in Japan. Clin Infect Dis. 2011; 52: 152-155. This article on PubMed
16. Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New Delhi metallo-beta-lactamase in Klebsiella pneumonia and Escherichia coli, Canada. Emerg Infect Dis. 2011; 17: 103-106. This article on PubMed
17. Zarfel G, Martin H, Leither E, Salzer HJF, Feierl G, Masoud L, et al. Emergence of New Delhi metallo-beta-lactamase, Australia. Emerg Infect Dis. 2011; 17: 129-130. This article on PubMed
18. Sidjabat H, Nimmo GR, Walsh TR, Binotto E, Htin A, Hayashi Y, et al. Carbapenam resistance in Klebsiella pneumonia due to New Delhi metallo-beta-lactamase. Clin Infect Dis. 2011 Feb 15; 52(4): 481-4. This article on PubMed
19. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early dissemination of NDM-1-and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program (2006-2007). Antimicrob Agents Chemother. 2011 Mar; 55(3): 1274-8. This article on PubMed
20. Poirel L, Pitout JD, Nordmann P. Carbapenamases: molecular diversity and clinical consequences. Future Microbiol. 2007; 2: 501-12. This article on PubMed
21. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007; 20: 440-458. This article on PubMed
22. Moellering RC. NDM-1: A cause for worldwide concern. New Eng J Med. 2010; 363: 2377-2379. This article on PubMed
23. Poirel L, Ros A, Carricajo A et al. Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother. 2011 Jan; 55(1): 447-8. This article on PubMed
24. Bonomo RA. New Delhi metallo-beta-lactamase and multidrug resistance: A global SOS?. Clin Infect Dis. 2011; 52: 485-487. This article on PubMed
25. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth information supplement update M100-S20-U: The Institute; 2010.
26. Tenove FC, Kalsi RK, Williams RB, Carry S, Stocker D, Lonswey JK, et al. Carbapenem resistance in Klebsiella pneumonia not detected by automated susceptibility testing. Emerg Infect Dis. 2006; 12: 1209-1213. This article on PubMed
27. Yan JJ, Hsueh PR, Tsai SH, Chuang CL. Comparison of the double disk, combined disk and Etest methods for detecting metallo-betalactamases in gram negative bacilli. Diagn Microbiol Infect Dis. 2004; 49: 5-11. This article on PubMed
28. Chu YW, Cheung TKM, Ngan JYW, Kam KM. EDTA susceptibility leading to false detection of metallo-beta-lactamase in Pseudomonas aeruginosa by Etest and in imipenem-EDTA disk method. Int J Antimicrob Agents. 2005; 26: 340-41. This article on PubMed
29. Lee KY, Chong HB, Shin YA, Kim D, Yong, Yum JH. Modified Hodge and EDTA disk synergy tests to screen metallo-beta-lactamase producing strain of pseudomonas an Acinetobacter species. Clin Microbiol Infect. 2001 Feb; 7(2): 88-91. This article on PubMed
30. Borer A, Saidel-Odes L, Riesenberg K, et al. Attributable mortality rate for carbapenem-resistannt Klebsiella pneumonia bacteremia. Infect Control Hosp Epidemiol. 2009; 30: 972-6. This article on PubMed
31. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008; 29: 1099-106. This article on PubMed
32. Pillai DR. New Delhi metallo-beta-lactamase-1 in Enterobacteriaceae: emerging resistance. CMAJ. 2011; 183: 59-64. This article on PubMed
33. Souli M, Kontopidou FV, Koratzanis E et al. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, Gramnegative and Gram-positive clinical isolates from Greek hospitals. Antimicrob Agents Chemother. 2006 Sep; 50(9): 3166-9. This article on PubMed
34. Antoniadou A, Kontopidou F, Poulakou G et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother. 2007 Apr; 59(4): 786-90. This article on PubMed
35. Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin Microbiol Rev. 2008; 21: 449-65. This article on PubMed
36. US Food and Drug Administration. FDA drug safety podcast for healthcare professionals: increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections. Silver Spring (MD) US Department of Health and Human Services; 2010. Available at www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcast/ucm224896.htm. Accessed 16 May 2011.
37. Cobo J, Morosini MI, Pintado V, Tato M, Samaranch N, Baquero F, et al. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase-producing Klebsiella pneumoniae epidemic clone. Diagn Microbiol Infect Dis. 2008; 60: 319-322. This article on PubMed
38. Pournaras S, Vrioni G, Neou E, Dendrinos J, Dimitroulia E, Poulou A, et al. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Int J Antimicrob Agents. 2011 Mar; 37(3): 244-7. This article on PubMed
39. Humphries RM, Kelesidis T, Bard JD, Ward KW, Bhattacharya D, Lewinsky MA. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high dose tigecycline and colistin. J Med Microbiol. 2010; 59: 1383-1386. This article on PubMed
40. Livermore DM, Mushtaq S, Warner M, Zhang J, Maharjan S, Doumith M, et al. Activity of NXL104 combinations with ceftazidime an aztreonam against carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2010; 55: 390-4. This article on PubMed
41. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extendedspectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010 Jan; 10(1): 43-50. This article on PubMed
42. Lakhani N. NHS "could save millions" by flying patients to India. The Independent. Available at: http://www.independent.co.uk/lifestyle/health-and-families/health-news/nhs-could-save-millions-by-flying-patient-to-india-1870215.html. Accessed 16 May 2011.
43. HPA. Health protection report. London: Health protection agency, 2009. Available at: http://www.hpa.uk/hpr/archives/2009/news0409.htm. Accessed 11 May 2011
44. Centers for disease control and prevention. Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase-United States, 2010. MMWR Morb Mortal Wkly Rep. 2010; 59: 750. This article on PubMed
45. Charan J, Yadav P, Saxena D, Kantharia ND. Drug advertisements published in Indian Medical Journals: Are they ethical?. J Pharm Bioallied Sci. 2011 Jul; 3(3): 403-6. This article on PubMed
46. Raghunath D. New metallo beta lactamase NDM-1. Indian J Med Res. 2010; 132: 478-481. This article on PubMed